At least 90% of ccRCC tumors are characterized by loss of von Hippel-Lindau (VHL) tumor suppressor function (Ricketts and Linehan, 2018), and VHL mediates proteasomal degradation of the HIF α-subunit (Schödel et al., 2016). This evidence concerns the gene VHL and neoplasm.